Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1989 1
1993 3
1997 2
1998 1
1999 1
2000 3
2001 1
2002 3
2003 4
2004 5
2005 8
2006 5
2007 11
2008 9
2009 15
2010 16
2011 17
2012 12
2013 9
2014 16
2015 16
2016 15
2017 12
2018 10
2019 7
2020 15
2021 17
2022 14
2023 13
2024 18
2025 21
2026 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

287 results

Results by year

Filters applied: . Clear all
Page 1
Rosacea management: A comprehensive review.
Sharma A, Kroumpouzos G, Kassir M, Galadari H, Goren A, Grabbe S, Goldust M. Sharma A, et al. J Cosmet Dermatol. 2022 May;21(5):1895-1904. doi: 10.1111/jocd.14816. Epub 2022 Feb 14. J Cosmet Dermatol. 2022. PMID: 35104917 Review.
Rosacea is a chronic cutaneous disorder affecting primarily the face, characterized by erythema, transient or persistent, telangiectasia, and inflammatory lesions including papulo-pustules and swelling. ...This article provides a comprehensive review of the various therapi …
Rosacea is a chronic cutaneous disorder affecting primarily the face, characterized by erythema, transient or persistent, telangiecta …
Rosacea.
Searle T, Al-Niaimi F, Ali FR. Searle T, et al. Br J Hosp Med (Lond). 2021 Feb 2;82(2):1-8. doi: 10.12968/hmed.2020.0417. Epub 2021 Feb 27. Br J Hosp Med (Lond). 2021. PMID: 33646026
Rosacea is a common cutaneous condition affecting predominantly the face. It is historically characterised into four subtypes: erythematotelangiectatic, papulopustular, phymatous and ocular rosacea. ...Oral doxycycline 40 mg modified release can be used as mo …
Rosacea is a common cutaneous condition affecting predominantly the face. It is historically characterised into four subtypes: erythe …
Guidelines of care for the management of acne vulgaris.
Reynolds RV, Yeung H, Cheng CE, Cook-Bolden F, Desai SR, Druby KM, Freeman EE, Keri JE, Stein Gold LF, Tan JKL, Tollefson MM, Weiss JS, Wu PA, Zaenglein AL, Han JM, Barbieri JS. Reynolds RV, et al. J Am Acad Dermatol. 2024 May;90(5):1006.e1-1006.e30. doi: 10.1016/j.jaad.2023.12.017. Epub 2024 Jan 30. J Am Acad Dermatol. 2024. PMID: 38300170
Strong recommendations are made for benzoyl peroxide, topical retinoids, topical antibiotics, and oral doxycycline. Oral isotretinoin is strongly recommended for acne that is severe, causing psychosocial burden or scarring, or failing standard oral or topical therapy. ...
Strong recommendations are made for benzoyl peroxide, topical retinoids, topical antibiotics, and oral doxycycline. Oral isotretinoin …
Effect of combined probiotics and doxycycline therapy on the gut-skin axis in rosacea.
Yu J, Duan Y, Zhang M, Li Q, Cao M, Song W, Zhao F, Kwok L-Y, Zhang H, Li R, Sun Z. Yu J, et al. mSystems. 2024 Nov 19;9(11):e0120124. doi: 10.1128/msystems.01201-24. Epub 2024 Oct 30. mSystems. 2024. PMID: 39475254 Free PMC article. Clinical Trial.
This study evaluated the impact of combined probiotics and doxycycline treatment on rosacea, emphasizing the gut-skin axis. Sixty rosacea patients were randomly assigned to the probiotic, placebo, or control groups. ...Our study supports the existence of a gu …
This study evaluated the impact of combined probiotics and doxycycline treatment on rosacea, emphasizing the gut-skin axis. Si …
Rosacea: Common Questions and Answers.
Frazier W, Zemtsov RK, Ge Y. Frazier W, et al. Am Fam Physician. 2024 Jun;109(6):533-542. Am Fam Physician. 2024. PMID: 38905551 Review.
Rosacea is a chronic inflammatory skin disease of the central face, affecting 5% of the population. ...Systemic treatments include nonselective beta blockers for flushing, low-dose doxycycline, and isotretinoin for papules and pustules. Rosacea can significan …
Rosacea is a chronic inflammatory skin disease of the central face, affecting 5% of the population. ...Systemic treatments include no …
S2k guideline: Rosacea.
Clanner-Engelshofen BM, Bernhard D, Dargatz S, Flaig MJ, Gieler U, Kinberger M, Klövekorn W, Kuna AC, Läuchli S, Lehmann P, Nast A, Pleyer U, Schaller M, Schöfer H, Steinhoff M, Schwennesen T, Werner RN, Zierhut M, Reinholz M. Clanner-Engelshofen BM, et al. J Dtsch Dermatol Ges. 2022 Aug;20(8):1147-1165. doi: 10.1111/ddg.14849. Epub 2022 Aug 5. J Dtsch Dermatol Ges. 2022. PMID: 35929658
This updated and upgraded S2k guideline deals with the diagnosis and treatment of rosacea, which is a common, chronic inflammatory skin disease mostly affecting the face. ...Systemic therapy is recommended for therapy-resistant and severe forms of rosacea papulopust …
This updated and upgraded S2k guideline deals with the diagnosis and treatment of rosacea, which is a common, chronic inflammatory sk …
Rosacea: Diagnosis and Treatment.
Oge' LK, Muncie HL, Phillips-Savoy AR. Oge' LK, et al. Am Fam Physician. 2015 Aug 1;92(3):187-96. Am Fam Physician. 2015. PMID: 26280139 Free article.
Once-daily brimonidine, a topical alpha-adrenergic receptor agonist, is effective in reducing erythema. Papulopustular rosacea can be treated with systemic therapy including tetracyclines, most commonly subantimicrobial-dose doxycycline. Phymatous rosacea is …
Once-daily brimonidine, a topical alpha-adrenergic receptor agonist, is effective in reducing erythema. Papulopustular rosacea can be …
Rosacea: An Update in Diagnosis, Classification and Management.
Kang CN, Shah M, Tan J. Kang CN, et al. Skin Therapy Lett. 2021 Jul;26(4):1-8. Skin Therapy Lett. 2021. PMID: 34347259 Free article.
The diagnosis and classification of rosacea has been modified to reflect presenting features. On exclusion of differentials, the diagnosis of rosacea is based on the presence of either (1) phymatous changes, or (2) centrofacial persistent erythema. ...Evidence-based …
The diagnosis and classification of rosacea has been modified to reflect presenting features. On exclusion of differentials, the diag …
Treatment of ocular rosacea: a systematic review.
Avraham S, Khaslavsky S, Kashetsky N, Starkey SY, Zaslavsky K, Lam JM, Mukovozov I. Avraham S, et al. J Dtsch Dermatol Ges. 2024 Feb;22(2):167-174. doi: 10.1111/ddg.15290. Epub 2024 Jan 20. J Dtsch Dermatol Ges. 2024. PMID: 38243868
Rosacea is a common chronic skin disease distributed primarily around the central face. Ocular manifestations of rosacea are poorly studied, and estimates of prevalence vary widely, ranging from 6% to 72% in the rosacea population. ...
Rosacea is a common chronic skin disease distributed primarily around the central face. Ocular manifestations of rosacea are p …
Treatment management for rosacea: current pharmacological and non-pharmacological options.
Volk K, Ulfers A, Yi RC, Feldman S, Taylor SL. Volk K, et al. Expert Rev Clin Pharmacol. 2025 Aug;18(8):589-605. doi: 10.1080/17512433.2025.2550727. Epub 2025 Sep 1. Expert Rev Clin Pharmacol. 2025. PMID: 40836652 Review.
INTRODUCTION: Rosacea is a chronic skin condition classified into four subtypes: erythematotelangiectatic, papulopustular, phymatous, and ocular involvement. ...Topical medications such as metronidazole, azelaic acid, ivermectin, and minocycline are used as first-line trea …
INTRODUCTION: Rosacea is a chronic skin condition classified into four subtypes: erythematotelangiectatic, papulopustular, phymatous, …
287 results